| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Owner | Director, 10% Owner
5 companies
Gadicke Ansbert is a Director, 10% Owner at KLRS with holdings across 5 companies. Recent SEC Form 4 filings include 3 buys and 8 sells.
Estimated insider holdings value: $436.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2021 | RPTX Repare Therapeutics Inc. | 10% Owner | Sell | 46,904 | $34.37 | $1,611,963.82 | -0.1% | -2.6% | -75.5% | |
| May 4, 2021 | HOWL Werewolf Therapeutics, Inc. | 10% Owner | Buy | 245,000 | $16.00 | $3,920,000.00 | +3.8% | +3.3% | -66.7% | |
| Mar 12, 2021 | RPTX Repare Therapeutics Inc. | 10% Owner | Sell | 695,000 | $28.18 | $19,585,100.00 | -12.9% | +19.5% | -56.9% | |
| Jan 12, 2021 | CGEM Cullinan Therapeutics, Inc. | Director, 10% Owner | Buy | 300,000 | $21.00 | $6,300,000.00 | +3.9% | - | - | |
| Jun 23, 2020 | RPTX Repare Therapeutics Inc. | 10% Owner | Buy | 500,000 | $20.00 | $10,000,000.00 | +10.2% | - | - |